Orange Book product · Generic (ANDA)
RIOCIGUAT
RIOCIGUAT
Generic (ANDA)ANDA 211135TE ABRX MSN
At a glance
Sep 01, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 01, 2022
3 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
RIOCIGUAT
Strength
0.5MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 211135
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of RIOCIGUAT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
